MedPath

STREPTASE INJ 250000UNIT/VIAL

STREPTASE INJ 250000UNIT/VIAL

Discontinued
DIN Number

00527157

Drug Class

Human

Market Date

Dec 31, 1981

Company
HC

hoechst canada inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00527157
AIG Number0107605001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
B01AD01 STREPTOKINASE
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification20:12.20
Health Canada Classification

ACTIVE INGREDIENTS (1)

STREPTOKINASEActive
Strength: 250000 UNIT / VIAL
Monograph: STREPTOKINASE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.